Real-World Patient Characteristics, Treatment Patterns, and Mutation Testing Patterns Among US Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations

被引：0
|
作者：
Jinghua He
Christopher D. Pericone
Julie Vanderpoel
机构：
[1] Janssen Scientific Affairs,
[2] LLC,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Biomarker testing; mutations; Exon 20 mutations; Immunotherapy; Next-generation sequencing; NSCLC; Treatment pathways; Tyrosine kinase inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3347 / 3360
页数：13
相关论文
共 50 条
  • [41] Real World Analysis Afatinib as a First Line Treatment Patients with Advanced Stage Non-small Cell Lung Cancer Harboring Uncommon EGFR Mutations
    Pham, L. V.
    Nguyen, H. M.
    Le, A. T.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S336 - S336
  • [42] Real-World Effectiveness of EGFR TKI First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer in US
    Gautam, S.
    Herms, L.
    Bartolome, L.
    Pastel, M.
    Wilner, K.
    Fisher, M.
    Ivanova, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S618 - S619
  • [43] Treatment patterns in patients with advanced non-small cell lung cancer (aNSCLC): real-world data from the United Kingdom
    Lester, J.
    Khan, S.
    Powell, C.
    Escriu, C.
    Hudson, E.
    Conn, A.
    Mansy, T.
    Chan, S.
    Brock, J.
    Zhuo, X.
    Durand, A.
    Zhang, X.
    Pawar, V.
    LUNG CANCER, 2020, 139 : S47 - S48
  • [44] Real-world treatment patterns and outcomes among unresectable Stage III Non-Small Cell Lung Cancer
    Arunachalam, Ashwini
    Sura, Sneha
    Murphy, John
    Conkling, Paul
    Goldschmidt, Jerome
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E13 - E13
  • [45] Real-world treatment patterns and outcomes among unresectable stage III non-small cell lung cancer
    Arunachalam, Ashwini
    Sura, Sneha
    Murphy, John
    Conkling, Paul
    Goldschmidt, Jerome
    PLOS ONE, 2024, 19 (11):
  • [46] Patterns of Treatment and Real-World Outcomes of Patients With Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations Receiving Mobocertinib: The EXTRACT Study
    Liu, Geoffrey
    Nyaw, Shi Feng
    Mok, Tony S. K.
    Curcio, Hubert
    Cortot, Alexis B.
    Kam, Tsz Yeung
    Descourt, Renaud
    Chik, Yin Kwan
    Cheema, Parneet
    Gwinnutt, James M.
    Churchill, Eric N.
    Nyborn, Justin
    Curran, Eileen
    Savell, Alexandra
    Yin, Yu
    Chong, Katie
    Tanaka-Chambers, Yuka
    Kretz, Julian
    Cadranel, Jacques
    CANCER MEDICINE, 2025, 14 (03):
  • [47] TREATMENT PATTERNS AMONG LOWER-INCOME INDIAN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER HARBORING EGFR MUTATIONS OR ALK REARRANGEMENTS
    Vashistha, Vishal
    Garg, Avneet
    Iyer, Hariharan
    Jain, Deepali
    Madan, Karan
    Guleria, Randeep
    Mohan, Anant
    CHEST, 2020, 158 (04) : 1869A - 1869A
  • [48] Overall Survival (OS) of EGFR Mutation Positive Non-Small Cell Lung Cancer Patients: Real-World Treatment Patterns of 1,660 Japanese Patients
    Yoshida, Kazushi
    Ohe, Yuichiro
    Inoue, Akira
    Kumagai, Toru
    Takeda, Masayuki
    Yamamoto, Nobuyuki
    Seto, Takashi
    Okamoto, Isamu
    Tashiro, Naoki
    Morita, Satoshi
    Fukuoka, Masahiro
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S336 - S337
  • [49] Real-world treatment patterns for metastatic non-small cell lung cancer at IRST Italy
    Altini, M.
    Massa, I.
    Balzi, W.
    Gentili, N.
    Foca, F.
    Danesi, V.
    Manunta, S.
    Burgio, M. A.
    Cravero, P.
    Ejzykowicz, F.
    Chandwani, S.
    Delmonte, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [50] Efficacy and safety of dacomitinib in advanced non-small cell lung cancer patients harboring uncommon EGFR mutations: Real-world evidence from China.
    Li, Hong-Shuai
    Yang, Guangjian
    Cai, Yi
    Li, Junling
    Xu, Haiyan
    Zhang, Tao
    Zhou, Liqiang
    Luo, Jiancheng
    Wang, Yuying
    Wang, Jinliang
    Hu, Xingsheng
    Liu, Peng
    Yan, Xiang
    Wang, Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345